Cardiology

Pregnancy does not increase long-term risks of mortality or adverse outcomes in individuals with hypertrophic cardiomyopathy.

Tafamidis reduces mortality and slows cardiac deterioration in ATTR-CM, improving imaging and clinical outcomes.

Study finds anti-CGRP mAbs do not increase cardiovascular risk in older or disabled patients with migraine.

Study links type 2 diabetes to impaired fibrous repair in atherosclerotic plaques, highlighting new treatment possibilities.

AI-enhanced ECG predicts hypertension and identifies patients at risk for adverse events, transforming preventive care approaches.

Chronic air pollution exposure significantly raises the risk of venous thromboembolism, underscoring its health impacts and clinical relevance.

AAS use may cause persistent coronary microvascular dysfunction, even years after cessation, highlighting long-term cardiovascular risks.

Aficamten improves symptoms, biomarkers, and quality of life in nonobstructive hypertrophic cardiomyopathy, promising better treatment options.